Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-14-002169)

Filing Details

Accession Number:: 0001140361-14-002169
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-14 18:11:01
Reporting Period:: 2014-01-10

Filing Date:: 2014-01-14
Accepted Time:: 2014-01-14 18:11:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1095981	Cytori Therapeutics Inc.	CYTX	Surgical & Medical Instruments & Apparatus (3841)	330827593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1168215	J Christopher Calhoun	3020 Callan Road San Diego CA 92121	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-01-10	500	$2.81	146,770	No	4	S	Direct
Common Stock	Disposition	2014-01-10	2,600	$2.82	144,170	No	4	S	Direct
Common Stock	Disposition	2014-01-10	1,200	$2.83	142,970	No	4	S	Direct
Common Stock	Disposition	2014-01-10	700	$2.84	142,270	No	4	S	Direct
Common Stock	Disposition	2014-01-10	600	$600.00	141,670	No	4	S	Direct
Common Stock	Disposition	2014-01-10	1,200	$2.86	140,470	No	4	S	Direct
Common Stock	Disposition	2014-01-10	900	$2.87	139,570	No	4	S	Direct
Common Stock	Disposition	2014-01-10	2,300	$2.88	137,270	No	4	S	Direct
Common Stock	Disposition	2014-01-10	3,399	$2.89	133,871	No	4	S	Direct
Common Stock	Disposition	2014-01-10	400	$2.90	133,471	No	4	S	Direct
Common Stock	Disposition	2014-01-10	2,100	$2.92	131,371	No	4	S	Direct
Common Stock	Disposition	2014-01-10	5,803	$2.93	125,568	No	4	S	Direct
Common Stock	Disposition	2014-01-10	4,043	$2.94	121,525	No	4	S	Direct
Common Stock	Disposition	2014-01-10	1,400	$2.95	120,125	No	4	S	Direct
Common Stock	Disposition	2014-01-10	2,000	$2.96	118,125	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	36,850	Indirect	By 401(k) Plan

Footnotes

Shares sold pursuant to a 10b5-1 Plan.